Dr. Neal R. Warshoff, DO

Dr. Warshoff practices at Pulmonary Specialists Of The Palm Beaches in Loxahatchee, Florida.

Dr. Warshoff's NPI, 1821198987, was assigned on September 25, 2006. Dr. Warshoff graduated from UNE College of Osteopathic Medicine in 1984. Dr. Warshoff holds Florida license OS5639.

Dr. Warshoff's primary practice is Pulmonary Specialists of the Palm Beaches, at 13005 Southern Blvd Suite 235 Suite 235, Loxahatchee, FL 33470-9272. The practice phone is (561) 795-1022.

Dr. Warshoff's primary practice is Pulmonary Specialists Of The Palm Beaches in Loxahatchee, Florida. Dr. Warshoff is also affiliated with HCA Florida JFK Hospital. The medical group on file is Pulmonary Specialists of the Palm Beaches. Dmand AI also links Dr. Warshoff to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Warshoff practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Warshoff's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Warshoff is board certified in 1989 - 2026 by the FL State License. Dr. Warshoff is licensed in Florida.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), hypersomnia, pleural effusion, pulmonary fibrosis, sleep apnea and tobacco use among the conditions Dr. Warshoff treats.

CMS data shows 2,497 Medicare services from Dr. Warshoff across 10 procedure codes in 2024, for 379 Medicare patients. Medicare paid $125,434 for them. Every service was in an office.

CMS counts 379 Medicare patients who saw Dr. Warshoff in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Warshoff's median patient age at 71, with 52% women.

In 2024, Dr. Warshoff wrote 4,326 Medicare Part D claims for 704 patients. 45% of them were for generic drugs. CMS names the drug for 4,189 of them, across 33 drugs with 11 or more claims each, at $2,690,775 in total drug cost. In 2023, CMS named 4,137 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Warshoff for performance year 2024, reported as part of a group. Dr. Warshoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Warshoff to 4 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Asthma, Respiratory Hypersensitivity and Bronchitis, Chronic. GlaxoSmithKline sponsors the most, 2.

CMS Open Payments shows 1,038 general payments to Dr. Warshoff from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. GlaxoSmithKline, LLC. paid the most, $4,649. It also lists 1 research payment totaling $7,250 in 2022.

Dmand AI lists 1 award for Dr. Warshoff, most recently CMS Stage 1 EHR in 2013.

Dr. Warshoff graduated from UNE College of Osteopathic Medicine in 1984. Dr. Warshoff is a member of AOA.

Dr. Warshoff is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.